2i Maintains a Naive Ground State in ESCs through Two Distinct Epigenetic Mechanisms

Stem Cell Reports. 2017 May 9;8(5):1312-1328. doi: 10.1016/j.stemcr.2017.04.001. Epub 2017 Apr 27.

Abstract

Mouse embryonic stem cells (ESCs) are maintained in serum with leukemia inhibitory factor (LIF) to maintain self-renewal and pluripotency. Recently, a 2i culture method was reported using a combination of MEK inhibition (MEKi) and GSK3 inhibition (GSK3i) with LIF to maintain ESCs in a naive ground state. How 2i maintains a ground state of ESCs remains elusive. Here we show that MEKi and GSK3i maintain the ESC ground state by downregulating global DNA methylation through two distinct mechanisms. MEK1 phosphorylates JMJD2C for ubiquitin-mediated protein degradation. Therefore, MEKi increased JMJD2C protein levels but decreased DNMT3 expression. JMJD2C promotes TET1 activity to increase 5-hydroxymethylcytosine (5hmC) levels. GSK3i suppressed DNMT3 expression, thereby decreasing DNA methylation without affecting 5hmC levels. Furthermore, 2i increased PRDM14 expression to inhibit DNMT3A/B protein expression by promoting G9a-mediated DNMT3A/B protein degradation. Collectively, 2i allows ESCs to maintain a naive ground state through JMJD2C-dependent TET1 activation and PRDM14/G9a-mediated DNMT3A/B protein degradation.

Keywords: 2i; G9a; GSK3i; JMJD2C; MEKi; PRDM14; TET1; methylation; phosphorylation.

MeSH terms

  • Animals
  • Cell Line
  • DNA (Cytosine-5-)-Methyltransferases / genetics
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • DNA Methylation
  • DNA-Binding Proteins
  • Epigenesis, Genetic*
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors*
  • Glycogen Synthase Kinase 3 / metabolism
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / metabolism*
  • Jumonji Domain-Containing Histone Demethylases / metabolism
  • MAP Kinase Kinase 1 / antagonists & inhibitors*
  • MAP Kinase Kinase 1 / metabolism
  • Mice
  • Mouse Embryonic Stem Cells / cytology
  • Mouse Embryonic Stem Cells / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Proteolysis
  • RNA-Binding Proteins
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Ubiquitination

Substances

  • DNA-Binding Proteins
  • Prdm14 protein, mouse
  • Protein Kinase Inhibitors
  • RNA-Binding Proteins
  • Transcription Factors
  • Jmjd2c protein, mouse
  • Jumonji Domain-Containing Histone Demethylases
  • DNA (Cytosine-5-)-Methyltransferases
  • Glycogen Synthase Kinase 3
  • MAP Kinase Kinase 1